Loading…

Neuronal deficits, not involving motor neurons, in mice lacking BDNF and/or NT4

NERVE growth factor and other neurotrophins signal to neurons through the Trk family of receptor tyrosine kinases 1–6 . TrkB is relatively promiscuous in vitro , acting as a receptor for brain-derived neurotrophic factor (BDNF), neurotrophin-4 (NT4) and, to a lesser extent, NT3 (refs 3–5). Mice lack...

Full description

Saved in:
Bibliographic Details
Published in:Nature (London) 1995-05, Vol.375 (6528), p.235-238
Main Authors: Conover, J. C, Erickson, J. T, Katz, D. M, Bianchi, L. M, Poueymirou, W. T, McClain, J, Pan, L, Helgren, M, Ip, N. Y, Boland, P, Friedman, B, Wiegand, S, Vejsada, R, Kato, A. C, DeChiara, T. M, Yancopoulos, G. D
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:NERVE growth factor and other neurotrophins signal to neurons through the Trk family of receptor tyrosine kinases 1–6 . TrkB is relatively promiscuous in vitro , acting as a receptor for brain-derived neurotrophic factor (BDNF), neurotrophin-4 (NT4) and, to a lesser extent, NT3 (refs 3–5). Mice lacking TrkB 7 show a more severe phenotype than mice lacking BDNF 8,9 , suggesting that TrkB may act as a receptor for additional ligands in vivo . To explore this possibility, we generated mice lacking NT4 or BDNF as well as mice lacking both neurotrophins. Unlike mice lacking other Trks 7,10,11 or neurotrophins 8,9,12–14 , NT4-deficient mice are long-lived and show no obvious neurological defects. Analysis of mutant phenotypes revealed distinct neuronal populations with different neurotrophin requirements. Thus vestibular and trigemi-nal sensory neurons require BDNF but not NT4, whereas nodose-petrosal sensory neurons require both BDNF and NT4. Motor neurons, whose numbers are drastically reduced in mice lacking TrkB, are not affected even in mice lacking both BDNF and NT4. These results suggest that another ligand, perhaps NT3, does indeed act on TrkB in vivo .
ISSN:0028-0836
1476-4687
DOI:10.1038/375235a0